Cell Growth & Differentiation, Vol 7, Issue 11 1461-1469, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Evidence for implication of muscle-specific calpain (p94) in myofibrillar integrity

S Poussard, M Duvert, D Balcerzak, S Ramassamy, JJ Brustis, P Cottin and A Ducastaing
Laboratoire de Biochimie et Technologie des Aliments, Institut des Sciences et Techniques des Aliments de Bordeaux, Universite Bordeaux l et UA-INRA 429, Talence, France.

The expression and the putative function(s) of a specific muscle calcium-dependent protease were investigated during myogenesis using rat myoblast primary cultures as a model. We have shown that the levels of p94 mRNAs increase as a function of myoblast differentiation, with the greatest amount of these RNAs being present during the later stages (8th day after plating). After an antisense oligodeoxyribonucleotide treatment with p94, ultrastructural studies show dramatic perturbations in differentiated myotubes and during myofibrillogenesis, mainly involving myofibrillar stability and Z-line integrity. These results may be related to recent findings about the role of p94 gene mutations in limbgirdle muscular dystrophy type 2A.

This article has been cited by other articles:

				M Fanin, L Nardetto, A C Nascimbeni, E Tasca, M Spinazzi, R Padoan, and C Angelini Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A J. Med. Genet., October 1, 2007; 44(10): 609 - 614. [Abstract] [Full Text] [PDF]

				K. Ojima, Y. Ono, N. Doi, K. Yoshioka, Y. Kawabata, S. Labeit, and H. Sorimachi Myogenic Stage, Sarcomere Length, and Protease Activity Modulate Localization of Muscle-specific Calpain J. Biol. Chem., May 11, 2007; 282(19): 14493 - 14504. [Abstract] [Full Text] [PDF]

				M. Fanin, A. C. Nascimbeni, L. Fulizio, C. P. Trevisan, M. Meznaric-Petrusa, and C. Angelini Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein Expression Am. J. Pathol., November 1, 2003; 163(5): 1929 - 1936. [Abstract] [Full Text] [PDF]

				L. V. B. Anderson, K. Davison, J. A. Moss, I. Richard, M. Fardeau, F. M. S. Tome, C. Hubner, A. Lasa, J. Colomer, and J. S. Beckmann Characterization of Monoclonal Antibodies to Calpain 3 and Protein Expression in Muscle from Patients with Limb-Girdle Muscular Dystrophy Type 2A Am. J. Pathol., October 1, 1998; 153(4): 1169 - 1179. [Abstract] [Full Text] [PDF]

				Y. Ono, H. Shimada, H. Sorimachi, I. Richard, T. C. Saido, J. S. Beckmann, S. Ishiura, and K. Suzuki Functional Defects of a Muscle-specific Calpain, p94, Caused by Mutations Associated with Limb-Girdle Muscular Dystrophy Type 2A J. Biol. Chem., July 3, 1998; 273(27): 17073 - 17078. [Abstract] [Full Text] [PDF]